All News

The efficacy of Shingrix was 97% in adults 50 years of age and older and 91% in adults 70 years of age and older over an extended follow-up period.

By supporting pharmacy students at Howard University, the fellowship hopes to expand the number of pharmacists of color in industry.

ASCP 2022 session presenters discuss strategies and tools that can help busy pharmacists stay up to date on current medical literature, guidelines, and media.

Expanding capacity of health care outcomes statutes aims to link specialists with general practices.

A researcher suggests that the levels of certain gut bacteria can predict the severity of symptoms that someone can experience when infected with COVID-19.

Automation can lessen the administrative burden on providers and accelerate specialty prescribing and dispensing to provide patients with quality care the moment they need it.

Look out for this month's latest news on Rx products.

Prior infection with SARS-CoV-2 decreased the risk of being reinfected with Omicron among unvaccinated and vaccinated individuals.

In a panel, pharmacy technicians across the world discuss the different continuing educations requirements in United States, Portugal, and the United Kingdom.

The test has been available under emergency use authorization (EUA) since March of 2020 and was the first commercial molecular test to receive EUA status.

Understanding the relationship between viral protein activity and rapid gene mutations could help researchers save more lives by creating a more effective flu vaccine.

The approval includes a novel dose and schedule of the combination, with a single dose of both drugs followed by durvalumab every 4 weeks in patients with unresectable hepatocellular carcinoma.

Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.

An ASCP 2022 session presenter explains some recent updates on vaccination guidance for the older adult population.

Researchers suggest that winter 2020 to 2021 public health interventions lowered natural immunity in children and put them at greater risk of respiratory infection after restrictions were lifted.

The treatment modulates the number of myosin heads that can enter “on actin” states and lowers the probability of force-producing (systolic) and residual (diastolic) cross-bridge formation.

Nivolumab may cut the risk of death or recurrent cancer by more than half, according to phase 3 trial results.

The risk of severe COVID-19 breakthrough infection was stronger with age and some comorbidities—the findings can inform antiviral distribution to prevent death or respiratory failure.

As a part of the Women in Pharmacy series, Catherine Duggan, FRPharmS, CEO of International Pharmaceutical Federation (FIP), explains her hopes for the pharmacy profession following pharmacists’ pivotal and expanding roles in the pandemic.

In a panel, pharmacy technicians across the world discuss how the role for pharmacy technicians will continue to grow post-pandemic in United States, Portugal, and the United Kingdom.

Tacrine was originally brought to the market in 1993 as an acetylcholinesterase inhibitor to fight the symptoms of Alzheimer disease.

The benefits of psychedelic medicine could expand into long-lasting and transformative therapeutics to treat depression better than selective serotonin reuptake inhibitors (SSRIs).

A more comprehensive body of regulations is required to achieve consistency and safety for patients.

Small choices during pharmacy school can help students on the path to becoming leaders in the field.

However, lack of access and awareness about pre-exposure prophylaxis, medication cost, and underestimating disease risk are all barriers to PrEP.

CMD drugs understands that pharmacists are on the front lines with patients, necessitating strong communication with providers.

Many pharmacy professionals feel discouraged, underutilized, and undervalued, but the support staff often saves the day.

Assessment follows state board of pharmacy ruling against request to open an in-office pharmacy.